Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Patanjali group eyes to be Rs 40,000-crore company in 2020-21

      Patanjali group eyes to be Rs 40,000-crore company in 2020-21

      Medical Dialogues Bureau25 Jan 2020 6:54 AM
      New Delhi: Haridwar-based Patanjali group, which has acquired debt-ridden Ruchi Soya, expects to have a turnover of Rs 35,000-Rs 40,000 crore in the...
      Sanofi Completes Acquisition of Synthorx

      Sanofi Completes Acquisition of Synthorx

      Medical Dialogues Bureau25 Jan 2020 6:49 AM
      PARIS- Sanofi has announced the successful completion of its acquisition of Synthorx, Inc. for $68 per share in cash. "The acquisition of...
      Alembic Pharma gets final USFDA nod for Bosentan tablets to treat pulmonary arterial hypertension

      Alembic Pharma gets final USFDA nod for Bosentan tablets to treat pulmonary arterial hypertension

      Medical Dialogues Bureau25 Jan 2020 6:41 AM
      New Delhi: Alembic Pharmaceuticals (Alembic) on Friday said it has received final nod from US health regulator for Bosentan tablets, used for...
      Strides Pharma arm gets tentative USFDA nod for skin ointment

      Strides Pharma arm gets tentative USFDA nod for skin ointment

      Medical Dialogues Bureau25 Jan 2020 6:34 AM
      New Delhi: Strides Pharma Science on Friday said its arm has received tentative nod from US health regulator for triamcinolone acetonide ointment used...
      Syngene International Limited announces Q3 FY20 results

      Syngene International Limited announces Q3 FY20 results

      Medical Dialogues Bureau25 Jan 2020 5:30 AM
      Reports 11% revenue growth in Q3 to Rs. 539 Cr
      Johnson & Johnson misses revenue estimates as blockbuster drugs disappoint

      Johnson & Johnson misses revenue estimates as blockbuster drugs disappoint

      Medical Dialogues Bureau24 Jan 2020 8:32 AM
      US: Johnson & Johnson narrowly missed quarterly revenue estimates on Wednesday as sales of its blockbuster psoriasis medicine Stelara and cancer...
      Wize Pharma Completes Patient Enrollment In Phase IV Study Of LO2A for the Treatment of Dry Eye Syndrome in Patients With Sjögrens Syndrome

      Wize Pharma Completes Patient Enrollment In Phase IV Study Of LO2A for the Treatment of Dry Eye Syndrome in Patients With Sjögren's Syndrome

      Medical Dialogues Bureau24 Jan 2020 6:01 AM
      Hod Hasharon: Wize Pharma a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced it has...
      FDA warns about potential cybersecurity vulnerabilities for certain GE Healthcare Clinical Information Central Stations and Telemetry Servers

      FDA warns about potential cybersecurity vulnerabilities for certain GE Healthcare Clinical Information Central Stations and Telemetry Servers

      Medical Dialogues Bureau24 Jan 2020 5:20 AM
      US: U.S. Food and Drug Administration is issuing a safety communication informing health care providers, facilities and patients about cybersecurity...
      Indian American Pharma millionaire sent to 5.5 years imprisonment for bribery for pushing opioids

      Indian American Pharma millionaire sent to 5.5 years imprisonment for bribery for pushing opioids

      Medical Dialogues Bureau24 Jan 2020 5:00 AM
      Boston: The founder of an Arizona pharmaceutical company was ordered to spend 5 1/2 years in prison Thursday for orchestrating a bribery and kickback...
      Cipla gets USFDA observations for its Goa facility

      Cipla gets USFDA observations for its Goa facility

      Medical Dialogues Bureau23 Jan 2020 9:53 AM
      New Delhi: Drug firm Cipla on Wednesday said it has received observations from the USFDA for its Goa manufacturing facility. It further said that the...
      Alembic Pharma gets final USFDA nod for Fenofibrate tablets

      Alembic Pharma gets final USFDA nod for Fenofibrate tablets

      Medical Dialogues Bureau23 Jan 2020 9:26 AM
      New Delhi: Alembic Pharmaceuticals on Thursday said it has received final nod from the US health regulator for fenofibrate tablets, which reduces...
      Medicine shops remain shut across Bihar as pharmacist oppose new regulation

      Medicine shops remain shut across Bihar as pharmacist oppose new regulation

      Medical Dialogues Bureau23 Jan 2020 8:50 AM
      Bihar: Medicine shops remained shut across Bihar yesterday in protest against the state government's new regulation that calls for mandatory...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok